The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Everolimus and exemestane for the treatment of metastatic hormone receptor-positive breast cancer patients previously treated with CDK4/6 inhibitor based therapies.
 
Madeline Cook
No Relationships to Disclose
 
Luai Al Rabadi
No Relationships to Disclose
 
Zahi Ibrahim Mitri
Consulting or Advisory Role - Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology